In recognition that body image and Eating Disorders are a pressing issue within the Australian community, the Commonwealth of Australia commissioned this report to be prepared by the Butterfly Foundation (“Butterfly”) on behalf of the National Eating Disorders Collaboration (NEDC).
Read moreGlucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more